PfENR inhibitors (Jacobus)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePfENR inhibitors (Jacobus)
Drug Alias NameFAS II inhibitors (Jacobus/MMV)MMV00/0053Plasmodium falciparum enoyl acyl carrier protein reductase inhibitors (Jacobus)fatty acid biosynthesis II inhibitors (Jacobus/MMV)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFatty acid synthase inhibitorsEnoyl-acyl-carrier protein reductase inhibitors
TargetsFatty acid synthaseEnoyl-acyl-carrier protein reductase
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJacobus Pharmaceutical Co. Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJacobus Pharmaceutical Co. IncMedicines for Malaria Venture
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A